{
    "clinical_study": {
        "@rank": "137954", 
        "arm_group": [
            {
                "arm_group_label": "Curodont Repair", 
                "arm_group_type": "Experimental", 
                "description": "Single application of Curodont Repair on treatment day D0 followed by a single application of fluoride (Duraphat) on D90."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Single application of Placebo on treatment day D0 followed by a single application of fluoride (Duraphat) on D90."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the therapeutic benefit of Curodont Repair for the\n      treatment of early buccal carious lesions compared to placebo."
        }, 
        "brief_title": "Effect of Curodont Repair or Placebo on the Remineralisation in Patients With Class 5 Carious Lesions", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Dental Caries", 
        "condition_browse": {
            "mesh_term": "Dental Caries"
        }, 
        "detailed_description": {
            "textblock": "All study participants must have two early class V carious lesions in need of a treatment\n      but not of an invasive treatment (split-mouth design). One lesion will be treated with\n      Curodont Repair and one with placebo as control (single application). 3 months later\n      fluoride (Duraphat) will be applied on both lesions. Study duration is 9 months. For\n      assessment visual and tactile evaluation, pictures, ECM, Diagnodent Pen, Canary System, VAS\n      is used."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Two class V carious lesions which do not require an invasive treatment\n\n          -  Size and form of the lesions: the lesions must both be fully visible and assessable\n             and accessible\n\n          -  Patients must be able and willing to observe good oral hygiene throughout the study\n\n             -\u2265 20 teeth\n\n          -  Permanent dentition and \u2264 65 years\n\n          -  Willing and able to attend the on-study visits\n\n          -  Willing and able to understand all study-related procedures\n\n          -  Written informed consent before participation in the study\n\n          -  Negative pregnancy test for women of childbearing potential\n\n        Exclusion Criteria:\n\n          -  The two study lesions must not be on adjacent teeth\n\n          -  No adjacent restoration on study tooth surface\n\n          -  Fluoride varnish application < 6 months prior to study treatment\n\n          -  Patient suffers from diabetes\n\n          -  Evidence of tooth erosion (due to excessive acidic drink consumption or reflux)\n\n          -  History of head and neck illnesses (e.g. head/neck cancer)\n\n          -  Any pathology or concomitant medication affecting salivary flow or dry mouth\n\n          -  Any metabolic disorders affecting bone turnover\n\n          -  Concurrent participation in another clinical trial with an investigational drug or\n             device or participation in another clinical trial with an investigational drug or\n             device within 30 days prior to study entry\n\n          -  Pregnant and lactating woman"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "14 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02020681", 
            "org_study_id": "P11-4-CURAF", 
            "secondary_id": "14934.1 PFLS-LS"
        }, 
        "intervention": [
            {
                "arm_group_label": "Curodont Repair", 
                "description": "Self-assembling peptide, biomimetic re-mineralisation", 
                "intervention_name": "Curodont Repair", 
                "intervention_type": "Device", 
                "other_name": "P11-4"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Formulation of Curodont Repair without the peptide P11-4", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Curodont Repair", 
                    "Placebo"
                ], 
                "description": "Single application on day D90", 
                "intervention_name": "Fluoride", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Fluorides"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Dental caries", 
            "Curodont Repair", 
            "P11-4"
        ], 
        "lastchanged_date": "December 19, 2013", 
        "location": {
            "contact": {
                "email": "Ivo.Krejci@unige.ch", 
                "last_name": "Ivo Krejci, Prof. Dr.", 
                "phone": "+41 223794101"
            }, 
            "contact_backup": {
                "email": "Alaa.Mannaa@unige.ch", 
                "last_name": "Alaa Mannaa, Dr.", 
                "phone": "+41 223794101"
            }, 
            "facility": {
                "address": {
                    "city": "Geneva", 
                    "country": "Switzerland", 
                    "zip": "1205"
                }, 
                "name": "University of Geneva - Devision of Cariology and Endodontology"
            }, 
            "investigator": [
                {
                    "last_name": "Ivo Krejci, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Alaa Mannaa, Dr.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Curodont Repair or Placebo on the Remineralisation in Patients With Class 5 Carious Lesions: A Mono-centre, Split-mouth, Double-blinded, Placebo Controlled, Randomised, Post Marketing Clinical Study", 
        "overall_contact": {
            "email": "Ivo.Krejci@unige.ch", 
            "last_name": "Ivo Krejci, Prof. Dr.", 
            "phone": "+41 223794101"
        }, 
        "overall_official": {
            "affiliation": "University of Geneva", 
            "last_name": "Ivo Krejci, Prof. Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The primary efficacy outcome is the difference of the change in the lesion size assessed by morphometry (standardised pictures) between investigational medical device and placebo group.", 
            "safety_issue": "No", 
            "time_frame": "D0, D30, D90, D270"
        }, 
        "reference": {
            "PMID": "23969679", 
            "citation": "Brunton PA, Davies RP, Burke JL, Smith A, Aggeli A, Brookes SJ, Kirkham J. Treatment of early caries lesions using biomimetic self-assembling peptides--a clinical safety trial. Br Dent J. 2013 Aug;215(4):E6. doi: 10.1038/sj.bdj.2013.741."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02020681"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Difference in the change of ECM values between investigational medical device and placebo group.", 
                "safety_issue": "No", 
                "time_frame": "D0, D30, D90, D180, D270"
            }, 
            {
                "measure": "Difference in the change of Diagnodent Pen values  between investigational medical device and placebo group.", 
                "safety_issue": "No", 
                "time_frame": "D0, D30, D90, D180, D270"
            }, 
            {
                "measure": "Difference in the change of Canary System values between investigational medical device and placebo group.", 
                "safety_issue": "No", 
                "time_frame": "D0, D30, D90, D180, D270"
            }, 
            {
                "measure": "Change in lesion's progression assessed by VAS between investigational medical device and placebo group.", 
                "safety_issue": "No", 
                "time_frame": "D0, D30, D90, D180, D270"
            }, 
            {
                "measure": "Cavitation rate between investigational medical device and placebo group.", 
                "safety_issue": "No", 
                "time_frame": "D0, D30, D90, D180, D270"
            }
        ], 
        "source": "Credentis AG", 
        "sponsors": {
            "collaborator": {
                "agency": "Swiss Commission for Technology and Innovation CTI", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Credentis AG", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}